GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $0.265 $0.480 Friday, 19th Apr 2024 WINT stock ended at $0.342. This is 0.589% more than the trading day before Thursday, 18th Apr 2024. During the day the stock fluctuated 9.06% from a day low at $0.330 to a day high of $0.360.
90 days $0.265 $0.532
52 weeks $0.265 $2.47

Historical Windtree Therapeutics Inc prices

Date Open High Low Close Volume
2024-01-02 $0.691 $0.730 $0.691 $0.698 48 204
2023-12-29 $0.718 $0.740 $0.671 $0.719 453 819
2023-12-28 $0.730 $0.730 $0.702 $0.720 198 568
2023-12-27 $0.725 $0.731 $0.710 $0.730 203 468
2023-12-26 $0.743 $0.743 $0.720 $0.730 24 169
2023-12-22 $0.730 $0.730 $0.720 $0.730 31 147
2023-12-21 $0.735 $0.735 $0.700 $0.724 78 087
2023-12-20 $0.767 $0.767 $0.720 $0.740 78 402
2023-12-19 $0.740 $0.777 $0.717 $0.739 76 867
2023-12-18 $0.750 $0.760 $0.710 $0.732 79 789
2023-12-15 $0.744 $0.750 $0.720 $0.730 167 399
2023-12-14 $0.730 $0.792 $0.725 $0.730 236 669
2023-12-13 $0.725 $0.761 $0.701 $0.730 109 658
2023-12-12 $0.790 $0.81 $0.720 $0.740 99 293
2023-12-11 $0.82 $0.82 $0.790 $0.793 73 845
2023-12-08 $0.90 $0.92 $0.753 $0.797 216 901
2023-12-07 $0.92 $0.93 $0.85 $0.88 58 130
2023-12-06 $0.92 $0.92 $0.86 $0.91 145 244
2023-12-05 $1.02 $1.02 $0.90 $0.91 255 246
2023-12-04 $1.05 $1.09 $1.00 $1.01 59 721
2023-12-01 $1.11 $1.11 $1.00 $1.05 152 745
2023-11-30 $0.98 $1.24 $0.96 $1.13 383 128
2023-11-29 $0.95 $0.99 $0.94 $0.96 113 528
2023-11-28 $0.97 $0.97 $0.92 $0.94 82 336
2023-11-27 $0.94 $1.00 $0.91 $0.93 99 899
Click to get the best stock tips daily for free!

About Windtree Therapeutics Inc

Windtree Therapeutics Windtree Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of acute cardiovascular and secondarily in acute pulmonary diseases. The company's lead development programs include istaroxime, which is in Phase IIb clinical trial for the treatment of acute decompensated heart failure, as well as in Phase IIa clinical trial for the treatment of early cardiogenic shock; AEROSURF,... WINT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT